Form 4: Inspire Medical Systems CTO John Rondoni Sells Shares Under 10b5-1 Trading Plan

John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold a portion of his common stock holdings on February 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 29, 2024, John Rondoni, the Chief Technology Officer of Inspire Medical Systems, sold shares of the company's common stock.
• The sales were executed under a Rule 10b5-1 trading plan established on November 30, 2023.
• A total of 6,405 shares were sold in multiple transactions at weighted average prices of $179.23, $179.98 and $179.26.
• The sales resulted in a decrease in Rondoni's direct holdings of Inspire Medical Systems common stock, with his remaining holdings totaling 15,657 shares after the final transaction.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. The sentiment is neutral as it simply reports transactions.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates